Trendlines Medical Singapore, a subsidiary of SGX-listed Israeli firm The Trendlines Group, is partnering Ozi Amanat’s venture capital firm K2 Global to participate in SPRING SEEDS Capital’s (SSC) S$100 million investment allocation via the Startup SG Equity scheme.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
